학술논문
Pembrolizumab plus docetaxel for patients with metastatic castration-resistant prostate cancer (mCRPC): Randomized, double-blind, phase 3 KEYNOTE-921 study.
Document Type
Journal
Author
Petrylak, Daniel P.; Ratta, Raffaele; Matsubara, Nobuaki; Korbenfeld, Ernesto Pablo; Gafanov, Rustem; Mourey, Loic; Todenhofer, Tilman; Gurney, Howard; Kramer, Gero; Bergman, Andre M.; Zalewski, Pawel; De Santis, Maria; Armstrong, Andrew J.; Gerritsen, Winald R.; Pachynski, Russell Kent; Byun, Seok-Soo; Li, Xin Tong; Schloss, Charles; Poehlein, Christian Heinrich; Fizazi, Karim
Source
Subject
Language
English
ISSN
15277755